Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.063
Filtrar
1.
Int J Mol Sci ; 23(2)2022 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-35054915

RESUMEN

The choice of effective biocides used for routine hospital practice should consider the role of disinfectants in the maintenance and development of local resistome and how they might affect antibiotic resistance gene transfer within the hospital microbial population. Currently, there is little understanding of how different biocides contribute to eDNA release that may contribute to gene transfer and subsequent environmental retention. Here, we investigated how different biocides affect the release of eDNA from mature biofilms of two opportunistic model strains Pseudomonas aeruginosa ATCC 27853 (PA) and Staphylococcus aureus ATCC 25923 (SA) and contribute to the hospital resistome in the form of surface and water contaminants and dust particles. The effect of four groups of biocides, alcohols, hydrogen peroxide, quaternary ammonium compounds, and the polymeric biocide polyhexamethylene guanidine hydrochloride (PHMG-Cl), was evaluated using PA and SA biofilms. Most biocides, except for PHMG-Cl and 70% ethanol, caused substantial eDNA release, and PHMG-Cl was found to block biofilm development when used at concentrations of 0.5% and 0.1%. This might be associated with the formation of DNA-PHMG-Cl complexes as PHMG-Cl is predicted to bind to AT base pairs by molecular docking assays. PHMG-Cl was found to bind high-molecular DNA and plasmid DNA and continued to inactivate DNA on surfaces even after 4 weeks. PHMG-Cl also effectively inactivated biofilm-associated antibiotic resistance gene eDNA released by a pan-drug-resistant Klebsiella strain, which demonstrates the potential of a polymeric biocide as a new surface-active agent to combat the spread of antibiotic resistance in hospital settings.


Asunto(s)
Antiinfecciosos/farmacología , Biopelículas/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , Desinfectantes/farmacología , Guanidinas/farmacología , Antiinfecciosos/síntesis química , Antiinfecciosos/química , ADN Bacteriano/química , Desinfectantes/química , Guanidinas/síntesis química , Guanidinas/química , Conformación de Ácido Nucleico/efectos de los fármacos , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/genética , Relación Estructura-Actividad
2.
J Med Chem ; 65(1): 436-459, 2022 01 13.
Artículo en Inglés | MEDLINE | ID: mdl-34964345

RESUMEN

Natural berberine-derived azolyl ethanols as new structural antibacterial agents were designed and synthesized for fighting with dreadful bacterial resistance. Partial target molecules exhibited potent activity against the tested strains, particularly, nitroimidazole derivative 4d and benzothiazole-2-thoil compound 18b, with low cytotoxicity both exerted strong antibacterial activities against multidrug-resistant Escherichia coli at low concentrations as 0.007 and 0.006 mM, respectively. Meanwhile, the active compounds 4d and 18b possessed the ability to rapidly kill bacteria and observably eradicate the E. coli biofilm by reducing exopolysaccharide content to prevent bacterial adhesion, which was conducive to alleviating the development of E. coli resistance. Preliminary mechanistic explorations suggested that the excellent antibacterial potential of molecules 4d and 18b might be attributed to their ability to disintegrate membrane, accelerate ROS accumulation, reduce bacterial metabolism, and intercalate into DNA groove. These results provided powerful information for the further exploitation of natural berberine derivatives against bacterial pathogens.


Asunto(s)
Antibacterianos/síntesis química , Antibacterianos/farmacología , Berberina/química , Berberina/farmacología , Escherichia coli/efectos de los fármacos , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Biopelículas/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Escherichia coli/metabolismo , Hemólisis/efectos de los fármacos , Humanos , Sustancias Intercalantes/síntesis química , Sustancias Intercalantes/farmacología , Pruebas de Sensibilidad Microbiana , Especies Reactivas de Oxígeno , Relación Estructura-Actividad
3.
Sci Rep ; 11(1): 24196, 2021 12 17.
Artículo en Inglés | MEDLINE | ID: mdl-34921232

RESUMEN

The German cockroach (Blattella germanica L.) is a major urban pest worldwide and is known for its ability to resist insecticides. Past research has shown that gut bacteria in other insects can metabolize xenobiotics, allowing the host to develop resistance. The research presented here determined differences in gut microbial composition between insecticide-resistant and susceptible German cockroaches and compared microbiome changes with antibiotic treatment. Cockroaches received either control diet or diet plus kanamycin (KAN) to quantify shifts in microbial composition. Additionally, both resistant and susceptible strains were challenged with diets containing the insecticides abamectin and fipronil in the presence and absence of antibiotic. In both strains, KAN treatment reduced feeding, leading to higher doses of abamectin and fipronil being tolerated. However, LC50 resistance ratios between resistant and susceptible strains decreased by half with KAN treatment, suggesting gut bacteria mediate resistance. Next, whole guts were isolated, bacterial DNA extracted, and 16S MiSeq was performed. Unlike most bacterial taxa, Stenotrophomonas increased in abundance in only the kanamycin-treated resistant strain and was the most indicative genus in classifying between control and kanamycin-treated cockroach guts. These findings provide unique insights into how the gut microbiome responds to stress and disturbance, and important new insights into microbiome-mediated insecticide resistance.


Asunto(s)
Antibacterianos/farmacología , Insecticidas/farmacología , Ivermectina/análogos & derivados , Pirazoles/farmacología , Animales , Blattellidae , ADN Bacteriano/efectos de los fármacos , Microbioma Gastrointestinal/efectos de los fármacos , Resistencia a los Insecticidas , Ivermectina/farmacología , Kanamicina/farmacología
4.
Bioorg Med Chem Lett ; 47: 128198, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-34119615

RESUMEN

A novel type of sulfonyl-hybridized imidazolyl ethanols as potential DNA-targeting antibacterial agents was constructed via the unique ring-opened reaction of oxiranes by imidazoles for the first time. Some developed target hybrids showed potential antimicrobial potency against the tested microbes. Especially, imidazole derivative 5f could strongly suppressed the growth of MRSA (MIC = 4 µg/mL), which was 2-fold and 16-fold more potent than the positive control sulfathiazole and norfloxacin. This compound exhibited quite low propensity to induce bacterial resistance. Antibacterial mechanism exploration indicated that compound 5f could embed in MRSA DNA to form steady 5f-DNA complex, which possibly hinder DNA replication to exert antimicrobial behavior. Molecular docking showed that molecule 5f could bind with dihydrofolate synthetase through hydrogen bonds. These results implied that imidazole derivative 5f could be served as a promising molecule for the exploration of novel antibacterial candidates.


Asunto(s)
Antibacterianos/farmacología , ADN Bacteriano/efectos de los fármacos , Etanol/farmacología , Imidazoles/farmacología , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Antibacterianos/síntesis química , Antibacterianos/química , Relación Dosis-Respuesta a Droga , Etanol/síntesis química , Etanol/química , Imidazoles/química , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Relación Estructura-Actividad
5.
Eur J Med Chem ; 217: 113340, 2021 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-33725630

RESUMEN

A novel class of 7-thiazoxime quinolones was developed as potential antimicrobial agents for the sake of bypassing resistance of quinolones. Biological assays revealed that some constructed 7-thiazoxime quinolones possessed effective antibacterial efficiency. Methyl acetate oxime derivative 6l exhibited 32-fold more active than ciprofloxacin against MRSA, which also possessed rapidly bactericidal ability and low toxicity towards mammalian cells. The combination use of 7-thiazoxime quinolone 6l and ciprofloxacin was able to improve antibacterial potency and effectively alleviate bacterial resistance. The preliminarily mechanism exploration revealed that compound 6l could destroy the cell membrane and insert into MRSA DNA to bind with DNA gyrase, then decrease the expression of gyrB and femB genes. The above results strongly suggested that methyl acetate oxime derivative 6l held a promise for combating MRSA infection.


Asunto(s)
Antibacterianos/farmacología , ADN Bacteriano/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Oximas/farmacología , Quinolonas/farmacología , Antibacterianos/síntesis química , Antibacterianos/química , Sitios de Unión/efectos de los fármacos , ADN Bacteriano/genética , Relación Dosis-Respuesta a Droga , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Oximas/síntesis química , Oximas/química , Quinolonas/síntesis química , Quinolonas/química , Relación Estructura-Actividad
6.
Biochem J ; 478(4): 855-869, 2021 02 26.
Artículo en Inglés | MEDLINE | ID: mdl-33522568

RESUMEN

Lupeol is known to be plentiful in fruits or plant barks and has an antimicrobial effect, however, its mode of action(s) has yet to be determined. To elucidate lupeol generates nitric oxide (NO), which is recognized for possessing an antimicrobial activity, intracellular NO was measured in Escherichia coli using DAF-FM. Using the properties of NO passing through plasma membrane easily, increased malondialdehyde levels have shown that lupeol causes lipid peroxidation, and the resulting membrane depolarization was confirmed by DiBAC4(3). These data indicated that lupeol-induced NO is related to the destruction of bacterial membrane. Further study was performed to examine whether NO, known as a cell proliferation inhibitor, affects bacterial cell division. As a result, DAPI staining verified that lupeol promotes cell division arrest, and followed by early apoptosis is observed in Annexin V/PI double staining. Even though these apoptotic hallmarks appeared, the endonuclease failed to perform properly with supporting data of decreased intracellular Mg2+ and Ca2+ levels without DNA fragmentation, which is confirmed using a TUNEL assay. These findings indicated that lupeol-induced NO occurs DNA fragmentation-independent bacterial apoptosis-like death (ALD). Additionally, lupeol triggers DNA filamentation and morphological changes in response to DNA repair system called SOS system. In accordance with the fact that ALD deems to SOS response, and that the RecA is considered as a caspase-like protein, increase in caspase-like protein activation occurred in E. coli wild-type, and no ΔRecA mutant. In conclusion, these results demonstrated that the antibacterial mode of action(s) of lupeol is an ALD while generating NO.


Asunto(s)
Antibacterianos/farmacología , Apoptosis/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Óxido Nítrico/fisiología , Triterpenos Pentacíclicos/farmacología , Calcio/metabolismo , División Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Fragmentación del ADN , ADN Bacteriano/efectos de los fármacos , ADN Bacteriano/metabolismo , Proteínas de Unión al ADN/metabolismo , Evaluación Preclínica de Medicamentos , Escherichia coli/metabolismo , Proteínas de Escherichia coli/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Magnesio/metabolismo , Lípidos de la Membrana/metabolismo , Potenciales de la Membrana/efectos de los fármacos , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/biosíntesis , Norfloxacino/farmacología , Rec A Recombinasas/metabolismo , Respuesta SOS en Genética
7.
J Med Food ; 24(2): 116-123, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33523769

RESUMEN

This study focused on the antibacterial effects of the endophytic fungi producing naringenin from Dalbergia odorifera T. Chen against Staphylococcus aureus. The antibacterial activity was measured by the inhibition diameters, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). The time-killing curve was also used to evaluate its antibacterial efficacy. The results of antibacterial activity determinations showed that endophytic fungi secondary metabolites can inhibit the growth of five pathogenic bacteria (S. aureus, Escherichia coli, Salmonella enteritidis, Pseudomonas aeruginosa, and Bacillus subtilis) and the most sensitive strain was S. aureus that had the MIC and MBC values of 0.13 and 0.50 mg/mL, respectively. The membrane permeability study was measured by a DNA leakage assay and electrical conductivity assay. Furthermore, the whole-cell protein lysates and DNA fragmentation assay was evaluated. The morphology of S. aureus treated with the endophytic fungi products was observed by scanning electron microscopy (SEM). The probable antibacterial mechanism of endophytic fungi secondary metabolites was the increased membrane permeability that leads to leaks of nucleic acids and proteins. SEM results further confirmed that the extracts can interfere with the integrity of S. aureus cell membrane and further inhibit the growth of bacteria, resulting in the death of bacteria. This study provides a new perspective for the antibacterial functions of endophytic fungi secondary metabolites for biomedical applications.


Asunto(s)
Proteínas Bacterianas , Membrana Celular , ADN Bacteriano , Dalbergia , Flavanonas , Hongos , Staphylococcus aureus , Antibacterianos/farmacología , Proteínas Bacterianas/efectos de los fármacos , Membrana Celular/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , Dalbergia/microbiología , Flavanonas/farmacología , Hongos/química , Pruebas de Sensibilidad Microbiana , Staphylococcus aureus/efectos de los fármacos
8.
Bioorg Chem ; 107: 104575, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33385978

RESUMEN

A new type of Schiff base-bridged multi-component sulfonamide imidazole hybrids with antimicrobial potential was developed. Some target compounds showed significant antibacterial potency. Observably, butylene hybrids 4h exhibited remarkable inhibitory efficacy against clinical MRSA (MIC = 1 µg/mL), but had no significant toxic effect on normal mammalian cells (RAW 264.7). The highly active molecule 4h was revealed by molecular modeling study that it could insert into the base-pairs of DNA hexamer duplex and bind with the ASN-62 residue of human carbonic anhydrase isozyme II through hydrogen bonding. Furthermore, further preliminary antibacterial mechanism experiments confirmed that compound 4h could effectively interfere with MRSA membrane and insert into bacterial DNA isolated from clinical MRSA strains through non-covalent bonding to produce a supramolecular complex, thus exerting its strong antibacterial efficacy by impeding DNA replication. These findings strongly implied that the highly active hybrid 4h could be used as a potential DNA-targeting template for the development of valuable antimicrobial agent.


Asunto(s)
Antibacterianos/farmacología , ADN Bacteriano/efectos de los fármacos , Imidazoles/farmacología , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Sulfonamidas/farmacología , Antibacterianos/síntesis química , Antibacterianos/química , Relación Dosis-Respuesta a Droga , Imidazoles/química , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Bases de Schiff/síntesis química , Bases de Schiff/química , Bases de Schiff/farmacología , Relación Estructura-Actividad , Sulfonamidas/química
9.
Expert Rev Anti Infect Ther ; 19(5): 601-618, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33081547

RESUMEN

INTRODUCTION: Lethal stressors, including antimicrobials, kill bacteria in part through a metabolic response proposed to involve reactive oxygen species (ROS). The quinolone anti-bacterials have served as key experimental tools in developing this idea. AREAS COVERED: Bacteriostatic and bactericidal action of quinolones are distinguished, with emphasis on the contribution of chromosome fragmentation and ROS accumulation to bacterial death. Action of non-quinolone antibacterials and non-antimicrobial stressors is described to provide a general framework for understanding stress-mediated, bacterial death. EXPERT OPINION: Quinolones trap topoisomerases on DNA in reversible complexes that block DNA replication and bacterial growth. At elevated drug concentrations, DNA ends are released from topoisomerase-mediated constraint, leading to the idea that death arises from chromosome fragmentation. However, DNA ends also stimulate repair, which is energetically expensive. An incompletely understood metabolic shift occurs, and ROS accumulate. Even after quinolone removal, ROS continue to amplify, generating secondary and tertiary damage that overwhelms repair and causes death. Repair may also contribute to death directly via DNA breaks arising from incomplete base-excision repair of ROS-oxidized nucleotides. Remarkably, perturbations that interfere with ROS accumulation confer tolerance to many diverse lethal agents.


Asunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Fluoroquinolonas/farmacología , Bacterias/genética , Bacterias/metabolismo , Muerte Celular/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , Humanos , Especies Reactivas de Oxígeno/metabolismo , Estrés Fisiológico/efectos de los fármacos
10.
J Pept Sci ; 27(3): e3294, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33283388

RESUMEN

With the extensive use of antibiotics in medicine, agriculture and food chemistry, the emergence of multi-drug resistant bacteria become more and more frequent and posed great threats to human health and life. So novel antimicrobial agents were urgently needed to defend the resistant bacteria. Jelleine-I was a small antimicrobial peptide (AMP) with eight amino acids in its sequence. It was believed to be an ideal template for developing antimicrobial agents. In the present study, the possible action mode against both gram-negative bacteria and gram-positive bacteria and in vivo antimicrobial activity was explored. Our results showed that Jelleine-I exhibits its antimicrobial activity mainly by disrupting the integrity of the cell membrane, which would not be affected by the conventional resistant mechanism. It also aims at some intracellular targets such as genomic DNA to inhibit the growth of microbes. In addition, the result of in vivo antimicrobial activity experiment showed that Jelleine-I performed a good therapeutic effect toward the mice with Escherichia coli infected peritonitis. Notably, Jelleine-I has negligible cytotoxicity toward the tested mammalian cells, indicating excellent cell selectivity between prokaryotic cells and eurkayotic cells. In summary, our results showed that Jelleine-I would be a potential candidate to be developed as a novel antimicrobial agent.


Asunto(s)
Antibacterianos/farmacología , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Proteínas Citotóxicas Formadoras de Poros/farmacología , Animales , Antibacterianos/química , Supervivencia Celular/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , ADN Bacteriano/genética , Células HEK293 , Humanos , Lipopolisacáridos/antagonistas & inhibidores , Lipopolisacáridos/farmacología , Ratones , Pruebas de Sensibilidad Microbiana , Proteínas Citotóxicas Formadoras de Poros/química , Células RAW 264.7
11.
Cell Mol Biol (Noisy-le-grand) ; 66(7): 51-55, 2020 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-33287922

RESUMEN

Ciprofloxacin hydrochloride and Norfloxacin are second-generation fluoroquinolone antibiotic against bacterial DNA gyrase, which reduces DNA strain throughout replication. As DNA gyrase is essential through DNA replication, subsequent DNA synthesis and cell division are inhibited. Direct photolysis of fluoroquinolones was studied by using UV irradiation in the presence or absence of other substances that generate free radicals. This study aimed to assess the effect of Ultraviolet B (UVB) irradiation in removing ciprofloxacin and norfloxacin by using a simulating model of wastewater contained urea at pH 4. A known concentration of ciprofloxacin and norfloxacin were prepared in an appropriate aqueous solution in presence or absence 0.2M urea and adjusted at pH 4. The dis-solved drugs were irradiated with UVB-lamp in a dark place for 60 minutes. The percent of removal and the rate of elimination (k) of each drug were calculated. The direct photolysis effect of UVB irradiation was observed with ciprofloxacin which amounted to 24.4% removal compared with12.4% removal of norfloxacin after 60 minutes of irradiation. The effect of UVB irradiation was enhanced by urea to reach 38.9% and 15% for ciprofloxacin and norfloxacin. The calculated k of ciprofloxacin has amounted to three folds of that of norfloxacin. Direct photolysis of ciprofloxacin and norfloxacin can be achieved simply by using a simulation model of 0.2 M urea and UVB irradiation at pH 4. UVB is highly effective in removing ciprofloxacin compared with norfloxacin by 2-3 folds.


Asunto(s)
División Celular/efectos de los fármacos , Ciprofloxacina/farmacología , Replicación del ADN/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , Norfloxacino/farmacología , Rayos Ultravioleta , Urea/química , División Celular/efectos de la radiación , Ciprofloxacina/efectos de la radiación , Medios de Cultivo , Replicación del ADN/efectos de la radiación , ADN Bacteriano/efectos de la radiación , Norfloxacino/efectos de la radiación , Análisis de Regresión
12.
Future Med Chem ; 12(19): 1709-1727, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-33028090

RESUMEN

Aim: With the increasing emergence of drug-resistant bacteria, the need for new antimicrobial agents has become extremely urgent. This work was to develop sulfonyl thiazoles as potential antibacterial agents. Results & methodology: Novel hybrids of sulfonyl thiazoles were developed from commercial acetanilide and acetylthiazole. Hybrids 6e and 6f displayed excellent inhibitory efficacy against clinical methicillin-resistant Staphylococcus aureus (MRSA) (minimum inhibitory concentration = 1 µg/ml) without obvious toxicity toward normal mammalian cells (RAW 264.7). The combination uses were found to improve the antimicrobial ability. Further preliminary antibacterial mechanism experiments showed that the active molecule 6f could effectively interfere with MRSA membrane and insert into MRSA DNA. Conclusion: Compounds 6e and 6f could serve as potential DNA-targeting templates toward the development of promising antimicrobial agents.


Asunto(s)
Antibacterianos/farmacología , ADN Bacteriano/efectos de los fármacos , Descubrimiento de Drogas , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Tiazoles/farmacología , Animales , Antibacterianos/síntesis química , Antibacterianos/química , Ratones , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Células RAW 264.7 , Tiazoles/síntesis química , Tiazoles/química
13.
Int J Food Microbiol ; 335: 108891, 2020 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-32977153

RESUMEN

Antimicrobial peptides are being explored for use as food preservatives to prevent foodborne diseases. In this study, bioinformatics tools were used to screen potential antimicrobial amino acid sequences from the whey acidic protein (WAP) of large yellow croaker (Larimichthys crocea). A novel antimicrobial peptide, designated as LCWAP, was identified and its antimicrobial effect and mechanism of action on Staphylococcus aureus was explored. The minimal inhibitory concentration (MIC) of LCWAP on S. aureus was 15.6 µg/mL. Transmission electron microscopy and laser confocal microscopy revealed that LCWAP kills bacteria by aggregating on the cell surface, destroying the integrity of bacterial cell membrane and resulting in the leakage of intracellular solutes. Moreover, peptide LCWAP inhibit biofilm formation, at concentrations of 1-1/16 × MIC, with biofilm formation found to decrease by 94.3%-13.7% upon LCWAP treatment. The ability of peptide LCWAP to bind bacteria DNA was revealed using electrophoresis analysis and ultraviolet absorption spectroscopy, with peptide LCWAP/DNA weight ratios of 125/1, and 17.3% decrease in the absorption peak of LCWAP. Furthermore, LCWAP had no cytotoxic effects on normal human hepatocytes, although it had strong inhibitory effect on S. aureus growth in milk.


Asunto(s)
Antibacterianos/farmacología , Proteínas de la Leche/farmacología , Leche/microbiología , Perciformes , Staphylococcus aureus/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Antibacterianos/química , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Membrana Celular/efectos de los fármacos , Supervivencia Celular , ADN Bacteriano/efectos de los fármacos , ADN Bacteriano/metabolismo , Conservantes de Alimentos/química , Conservantes de Alimentos/farmacología , Humanos , Pruebas de Sensibilidad Microbiana , Proteínas de la Leche/química , Fragmentos de Péptidos/química , Fragmentos de Péptidos/metabolismo , Fragmentos de Péptidos/farmacología , Staphylococcus aureus/crecimiento & desarrollo
14.
Toxicol Mech Methods ; 30(9): 672-678, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32752976

RESUMEN

Tobacco products contain thousands of chemicals, including addictive and toxic chemicals. We utilized in silico toxicology tools to predict in a validation test and in a separate screening test, the mutagenic potential of chemicals reported in tobacco products and tobacco smoke. Different publicly available (quantitative) structure-activity relationship (Q)SAR software platforms were used in this study. The models were validated against 900 chemicals relevant to tobacco for which experimental Ames mutagenicity data are available from public sources. The predictive performance of the individual and combined (Q)SAR models was evaluated using various performance metrics. All the (Q)SAR models represented >95% of the tobacco chemical space indicating a high potential for screening tobacco products. All the models performed well and predicted mutagens and nonmutagens with 75-95% accuracy, 66-94% sensitivity and 73-97% specificity. Subsequently, in a screening test, a combination of complementary SAR-based and QSAR-based models was used to predict the mutagenicity of 6820 chemicals catalogued in tobacco products and/or tobacco smoke. More than 1200 chemicals identified in tobacco products are predicted to have mutagenic potential, with 900 potential mutagens in tobacco smoke. This research demonstrates the validity of in silico (Q)SAR tools to make mutagenicity predictions for chemicals in tobacco products and/or tobacco smoke, and suggest they hold utility as screening tools for hazard identification to inform tobacco regulatory science.


Asunto(s)
Simulación por Computador , ADN Bacteriano/efectos de los fármacos , Modelos Moleculares , Mutagénesis , Pruebas de Mutagenicidad , Humo/efectos adversos , Productos de Tabaco/toxicidad , ADN Bacteriano/genética , Bases de Datos de Compuestos Químicos , Ensayos Analíticos de Alto Rendimiento , Humanos , Estructura Molecular , Relación Estructura-Actividad Cuantitativa , Reproducibilidad de los Resultados , Medición de Riesgo
15.
Chem Res Toxicol ; 33(9): 2276-2285, 2020 09 21.
Artículo en Inglés | MEDLINE | ID: mdl-32812424

RESUMEN

DNA damage can occur naturally or through environmental factors, leading to mutations in DNA replication and genomic instability in cells. Normally, natural d-nucleotides were selected by DNA polymerases. The template l-thymidine (l-T) has been shown to be bypassed by several types of DNA polymerases. However, DNA replication fidelity of nucleotide incorporation opposite l-thymidine in vivo remains unknown. Here, we constructed plasmids containing a restriction enzyme (PstI) recognition site in which the l-T lesion was site-specifically located within the PstI recognition sequence (CTGCAG). Further, we assessed the efficiencies of nucleotide incorporation opposite the l-T site and l-T lesion bypass replication in vitro and in vivo. We found that recombinants containing the l-T lesion site inhibited DNA replication. In addition, A was incorporated opposite the l-T lesion by routine PCR assay, whereas preference for nucleotide incorporation opposite the l-T site was A (13%), T (22%), C (46%), and G (19%), and no nucleotide insertion and deletions were detected in E. coli cells. In particular, a novel restriction enzyme-mediated method for detection of the mutagenic properties of DNA lesion was established, which allows us to readily detect restriction-digestion of the l-T-bearing plasmids. The study provided significant insight into how mirror-image nucleosides perturb the fidelity of DNA replication in vivo and whether they elicit mutagenic effects, which may help to understand both how DNA damage interferes with the flow of genetic information during DNA replication and development of diseases caused by gene mutation.


Asunto(s)
Replicación del ADN/efectos de los fármacos , ADN Bacteriano/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Timidina/farmacología , Daño del ADN , Replicación del ADN/genética , ADN Bacteriano/genética , Escherichia coli/citología
16.
Toxicol Mech Methods ; 30(7): 508-525, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32375587

RESUMEN

Pathogenic microorganism delays wound-healing process by causing infection. In recent years, researchers have developed various kinds of photo-active nanomaterials with enhanced antibacterial properties. This work focus on the preparation of graphene oxide and TiO2 nanocomposites (GO/TiO2) as a visible light-induced high efficiency antibacterial material. The hydrothermal method was used for the synthesis of GO/TiO2 nanocomposites at 180 oC for 3 h with different loading percentages of GO (10, 20, 30, 40 and 50 wt. %). The systematic characterization tools including X-ray diffraction analysis, FT-IR, UV-vis, Raman and TEM which were used to understand the physicochemical properties of the prepared GO/TiO2 nanocomposites. Furthermore, GO/TiO2 nanocomposites were used as photocatalytic active materials against wound infection-causing bacteria in the presence of visible light irradiation. The possible antibacterial mechanism under presence and absence of light were depicted. The antibacterial mechanism of the GO/TiO2 nanocomposite was investigated on wound infection-causing bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Enterococcus faecalis. The high hemocompatibility and the cellular biocompatibility of the nanocomposite aids in using it for wound-healing application. Overall, the results suggest that the GO/TiO2 nanocomposite could be developed as a photo-active nanomaterial against pathogenic microorganisms that are present in wound.


Asunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Grafito/farmacología , Nanocompuestos , Titanio/farmacología , Cicatrización de Heridas/efectos de los fármacos , Infección de Heridas/tratamiento farmacológico , Animales , Antibacterianos/efectos de la radiación , Antibacterianos/toxicidad , Bacterias/genética , Bacterias/crecimiento & desarrollo , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Supervivencia Celular/efectos de los fármacos , Daño del ADN , ADN Bacteriano/efectos de los fármacos , ADN Bacteriano/genética , Grafito/efectos de la radiación , Grafito/toxicidad , Hemólisis/efectos de los fármacos , Humanos , Ratones , Viabilidad Microbiana/efectos de los fármacos , Células 3T3 NIH , Estrés Oxidativo/efectos de los fármacos , Procesos Fotoquímicos , Titanio/efectos de la radiación , Titanio/toxicidad , Infección de Heridas/microbiología
17.
Future Med Chem ; 12(8): 709-739, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32208986

RESUMEN

Aim: Phenanthridines are an essential class of nitrogenous heterocycles with extensive applications in medicinal chemistry. The development of efficient and eco-friendly methods for the preparation of chirally pure dihydropyrrolo[1,2-f]phenanthridines (5a-h), and their in vitro evaluation and modeling studies as potential anticancer, antioxidant and DNA cleavage agents is reported. Methodology & results: Compounds 5a-h were prepared through a facile one-pot synthesis and characterized by infrared, high resolution mass spectrometry, 1H and 13C nuclear magnetic resonance. The molecules were subjected to virtual screening and docking analysis against selected human molecular targets. Compound 5g displayed good binding properties as well as significant anticancer and DNA cleavage activity. Conclusion: Compound 5g has been identified as a potential lead candidate for further testing against additional cancer cell lines and animal models in future.


Asunto(s)
Antineoplásicos/farmacología , Fenantridinas/farmacología , Antineoplásicos/síntesis química , Antineoplásicos/química , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , División del ADN , ADN Bacteriano/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Simulación del Acoplamiento Molecular , Estructura Molecular , Fenantridinas/síntesis química , Fenantridinas/química , Células Tumorales Cultivadas
18.
Biomed Res Int ; 2020: 3104613, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32190658

RESUMEN

Probiotics may offer an attractive alternative for standard antibiotic therapy to treat Clostridium difficile infections (CDI). In this study, the antibacterial mechanism in vitro of newly isolated B. amyloliquefaciens C-1 against C. difficile was investigated. The lipopeptides surfactin, iturin, and fengycin produced by C-1 strongly inhibited C. difficile growth and viability. Systematic research of the bacteriostatic mechanism showed that the C-1 lipopeptides damage the integrity of the C. difficile cell wall and cell membrane. In addition, the lipopeptide binds to C. difficile genomic DNA, leading to cell death. Genome resequencing revealed many important antimicrobial compound-encoding clusters, including six nonribosomal peptides (surfactins (srfABCD), iturins (ituABCD), fengycins (fenABCDE), bacillibactin (bmyABC), teichuronic, and bacilysin) and three polyketides (bacillaene (baeEDLMNJRS), difficidin (difABCDEFGHIJ), and macrolactin (mlnABCDEFGHI)). In addition, there were other beneficial genes, such as phospholipase and seven siderophore biosynthesis gene clusters, which may contribute synergistically to the antibacterial activity of B. amyloliquefaciens C-1. We suggest that proper application of antimicrobial peptides may be effective in C. difficile control.


Asunto(s)
Antibacterianos/farmacología , Bacillus amyloliquefaciens/genética , Bacillus amyloliquefaciens/metabolismo , Clostridioides difficile/efectos de los fármacos , Lipopéptidos/farmacología , Antibacterianos/aislamiento & purificación , Muerte Celular/efectos de los fármacos , Clostridioides difficile/genética , Clostridioides difficile/crecimiento & desarrollo , ADN Bacteriano/efectos de los fármacos , Dipéptidos/farmacología , Genoma Bacteriano , Lipopéptidos/biosíntesis , Lipopéptidos/genética , Lipopéptidos/aislamiento & purificación , Familia de Multigenes , Oligopéptidos , Péptidos Cíclicos/farmacología , Policétidos/farmacología , Probióticos , Metabolismo Secundario , Ácidos Urónicos/farmacología , Secuenciación Completa del Genoma
19.
Bioorg Chem ; 98: 103705, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32171992

RESUMEN

Genotoxic agents are capable of causing damage to genetic material and the cumulative DNA damage causes mutations, involved in the development of various pathological conditions, including cancer. Antigenotoxic agents possess the potential to counteract these detrimental cellular modifications and may aid in preventing, delaying, or decreasing the severity of these pathological conditions. An important class of natural products for which promising antigenotoxic activities have already been shown, are the flavonoids. In this research, we investigated the quantitative structure-activity relationship (QSAR) of flavonoids and their antigenotoxic activity against benzo[a]pyrene (B[a]P) and its mutagenic metabolite B[a]P-7,8-diol-9,10-epoxide-2. Random Forest classification models were developed, which could be useful as a preliminary in silico evaluation tool, before performing in vitro or in vivo experiments. The descriptors G2S and R8s. were the most significant for predicting the antigenotoxic potential.


Asunto(s)
Benzo(a)pireno/antagonistas & inhibidores , ADN Bacteriano/efectos de los fármacos , Desarrollo de Medicamentos , Flavonoides/farmacología , Salmonella typhimurium/efectos de los fármacos , Daño del ADN , ADN Bacteriano/genética , Relación Dosis-Respuesta a Droga , Flavonoides/síntesis química , Flavonoides/química , Modelos Moleculares , Estructura Molecular , Relación Estructura-Actividad Cuantitativa , Salmonella typhimurium/genética
20.
Sci Rep ; 10(1): 4421, 2020 03 10.
Artículo en Inglés | MEDLINE | ID: mdl-32157153

RESUMEN

Antibiotic resistance has become a major concern for human and animal health. As fluoroquinolones have been extensively used in human and veterinary medicine, there has also been the rapid emergence and spread of antimicrobial resistance around the world. Here, we analysed the microbiome of goat milk using samples from healthy goats and those diagnosed with persistent mastitis and treated using the antibiotic enrofloxacin with 16S rRNA amplicon sequencing. We selected a group of 11 goats and 22 samples of milk that did not respond clinically to enrofloxacin treatment. Milk samples were evaluated before and after treatment to verify changes of the microbiota; the three first lactating goats were selected from the healthy control group. The milk samples from the healthy control animals presented a larger abundance of different species of bacteria of the Staphylococcus genus, but a smaller number of different genera, which indicated a more specific niche of resident bacteria. The Firmicutes phylum was predominantly different between the studied groups. Samples from before-treatment animals had a higher number of new species than those from the control group, and after being treated again. These microbiota received new bacteria, increasing the differences in bacteria even more in relation to the control group. Genotypes such as Trueperella and Mannheimia, between other genera, had a high abundance in the samples from animals with persistent mastitis. The dysbiosis in this study, with marked evidence of a complex microbiota in activity in cases of the failure of antimicrobial treatment for persistent chronic mastitis, demonstrates a need to improve the accuracy of pathogen identification and increases concern regarding antibiotic treatments in milk production herds.


Asunto(s)
Antibacterianos/administración & dosificación , Bacterias/clasificación , Enrofloxacina/administración & dosificación , Enfermedades de las Cabras/tratamiento farmacológico , Mastitis/veterinaria , Leche/microbiología , Animales , Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Bacterias/genética , Bacterias/aislamiento & purificación , Estudios de Casos y Controles , ADN Bacteriano/efectos de los fármacos , ADN Ribosómico/genética , Enrofloxacina/farmacología , Femenino , Cabras , Mastitis/tratamiento farmacológico , Microbiota/efectos de los fármacos , Leche/efectos de los fármacos , Filogenia , ARN Ribosómico 16S/genética , Análisis de Secuencia de ADN/veterinaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...